Clearside Biomedical, Inc. (CLSDQ)
About Clearside Biomedical, Inc.
CLEARSIDE BIOMEDICAL INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2024
- $1.7M
- Net income
- -$34.4M
- Total assets
- $25.1M
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Clearside Biomedical, Inc. (CLSDQ) Stock Price
- Reported a net loss of $34.4M in FY2024.
- Trading 80% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Clearside Biomedical, Inc..
Write a review
Clearside Biomedical, Inc.: frequently asked questions
Is Clearside Biomedical, Inc. an American company?
Clearside Biomedical, Inc. is a US-based company headquartered in Alpharetta, Georgia, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Clearside Biomedical, Inc. headquartered?
Clearside Biomedical, Inc. is headquartered in Alpharetta, Georgia, United States.
Is Clearside Biomedical, Inc. publicly traded?
Yes — Clearside Biomedical, Inc. is a publicly traded company. Its stock trades under the ticker symbol CLSDQ on the OTC.
What does Clearside Biomedical, Inc. do?
Clearside Biomedical, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
